Cipla will market Eli Lilly’s diabetes and weight-loss drug Mounjaro as Yurpeak in India, enhancing accessibility and ...

Under the agreement, Eli Lilly will continue to market tirzepatide under brand name Mounjaro, while Cipla will have the ...

Karen McGonigal, 53, died days after she was illegally administered a dose of semaglutide - the powerful ingredient behind Ozempic and Wegovy - in May.

Eli Lilly has signed a licensing deal with Cipla to market its blockbuster weight-loss drug under the brand name Yurpeak in ...

Karen McGonigal's three daughters say she became "desperate" to lose weight after a long-term relationship ended - with ...

Eli Lilly has teamed up with Cipla to market its popular weight-loss drug Mounjaro in India. The medication, which is used ...

IT’S not your imagination – everyone really is getting thinner. From the girls’ WhatsApp chat to your gym’s changing room, ...

Eli Lilly's launch of Mounjaro in India in March 2025 was the first step of Tirzepatide in the country. In June 2025, the ...

Eli Lilly signed an agreement with Cipla , allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a ...

In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) ...

Experts warn fake ‘skinny jabs’ are circulating in the UK. Here are 9 red flags to watch for – and what to do if you think ...

India has about 101 million people living with diabetes and nearly half of these in the adult patients category are being ...